We are live on ! Find out more
NCM

Narwhal Capital Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$752M
AUM Growth
+$61.4M
Cap. Flow
-$5.24M
Cap. Flow %
-0.7%
Top 10 Hldgs %
35.98%
Holding
169
New
16
Increased
54
Reduced
64
Closed
8

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.72M
2
ADBE icon
Adobe
ADBE
+$2.37M
3
META icon
Meta Platforms (Facebook)
META
+$1.94M
4
DE icon
Deere & Co
DE
+$1.89M
5
DIS icon
Walt Disney
DIS
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 16.8%
2 Healthcare 12.55%
3 Financials 9.82%
4 Consumer Staples 9.46%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$295B
$9.52M 1.27%
94,072
+22,399
+31% +$2.11M
DEO icon
27
Diageo
DEO
$53.6B
$9.32M 1.24%
52,321
+4,032
+8% +$707K
NXRT
28
NexPoint Residential Trust
NXRT
$652M
$8.97M 1.19%
206,209
+15,948
+8% +$713K
NVDA icon
29
NVIDIA
NVDA
$5.42T
$8.61M 1.15%
589,170
-65,420
-10% -$959K
LHX icon
30
L3Harris
LHX
$53.4B
$8.44M 1.12%
40,542
-1,662
-4% -$375K
ADI icon
31
Analog Devices
ADI
$190B
$8.33M 1.11%
50,780
+4,479
+10% +$699K
V icon
32
Visa
V
$677B
$8.16M 1.08%
39,261
-874
-2% -$176K
LMT icon
33
Lockheed Martin
LMT
$136B
$7.73M 1.03%
15,892
+63
+0.4% +$29.3K
LLY icon
34
Eli Lilly
LLY
$1.06T
$7.44M 0.99%
20,331
+3,133
+18% +$1.11M
COST icon
35
Costco
COST
$420B
$7.3M 0.97%
15,983
+536
+3% +$262K
TGT icon
36
Target
TGT
$68B
$7.12M 0.95%
47,776
-8,576
-15% -$1.35M
NOV icon
37
NOV
NOV
$7B
$7.09M 0.94%
339,527
-22,655
-6% -$475K
MRK icon
38
Merck
MRK
$318B
$6.68M 0.89%
60,226
-261
-0.4% -$26.7K
CVX icon
39
Chevron
CVX
$366B
$6.42M 0.85%
35,788
+160
+0.4% +$27.9K
GD icon
40
General Dynamics
GD
$106B
$6.35M 0.84%
25,593
+7
+0% +$1.71K
IWF icon
41
iShares Russell 1000 Growth ETF
IWF
$128B
$5.69M 0.76%
106,272
-20
-0% -$1.1K
CAT icon
42
Caterpillar
CAT
$387B
$5.04M 0.67%
21,032
-1,235
-6% -$269K
NVS icon
43
Novartis
NVS
$297B
$5.01M 0.67%
55,279
-90
-0.2% -$7.58K
ELV icon
44
Elevance Health
ELV
$85.5B
$4.97M 0.66%
9,692
-30
-0.3% -$15.2K
GM icon
45
General Motors
GM
$76.8B
$4.6M 0.61%
136,640
-10,586
-7% -$391K
CVS icon
46
CVS Health
CVS
$122B
$4.58M 0.61%
49,190
+4,997
+11% +$482K
CHX
47
DELISTED
ChampionX
CHX
$4.42M 0.59%
152,392
-13,658
-8% -$377K
BX icon
48
Blackstone
BX
$110B
$4.33M 0.58%
58,412
-5,030
-8% -$434K
ADSK icon
49
Autodesk
ADSK
$52.6B
$4.21M 0.56%
22,509
-787
-3% -$158K
ADBE icon
50
Adobe
ADBE
$105B
$4.18M 0.56%
12,409
-7,399
-37% -$2.37M

Similar funds

Narwhal Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Narwhal Capital Management held 169 positions worth $752M, up 8.9% from $691M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Narwhal Capital Management's Q4 2022 filing shows 16 new, 54 increased, 64 reduced and 8 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 15,900 shares worth $2.16M. The largest sale was Pfizer, an estimated $2.72M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Narwhal Capital Management's largest Q4 2022 buy was State Street Health Care Select Sector SPDR ETF: 15,900 shares worth $2.16M.
  • Narwhal Capital Management added most to RTX Corp in Q4 2022, an estimated $3.1M increase.
  • Narwhal Capital Management's biggest Q4 2022 reduction was Pfizer, cutting an estimated $2.72M.
  • Narwhal Capital Management fully exited ProShares UltraPro Short S&P 500 in Q4 2022, selling an estimated $390K.
  • Narwhal Capital Management's ten largest holdings make up 36% of its $752M portfolio in Q4 2022.
  • Narwhal Capital Management opened 16 new positions and closed 8 in Q4 2022.
  • Narwhal Capital Management's portfolio value rose 8.9% quarter-over-quarter to $752M.

Based on Narwhal Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.